InvestorsHub Logo
Followers 22
Posts 587
Boards Moderated 0
Alias Born 08/19/2020

Re: None

Friday, 10/16/2020 9:17:32 AM

Friday, October 16, 2020 9:17:32 AM

Post# of 44690
So just a little Friday analysis. Please help me take a closer look at Javitt's statement from the Solebury Trout presentation...

"The Covid study is moving forward with incredible velocity. We expect to read out the Phase three trial by the end of the year. But, two weeks from now, there's going to be a meeting of the data safety monitoring board (DSMB). And they're going to review the first 102 patients in the trial. They have the potential to see both futility, which we hope they won't see, or perhaps they will see overwhelming evidence of efficacy. Either, which would lead to STOPPING THE TRIAL."

I don't know about you, but I get the sense Javitt is expecting them to stop the trial at the DSMB meeting, due to "overwhelming evidence of efficacy".

QUESTIONS:
Does anyone know exactly what day that meeting is?

Also... do we think that is the day they will actually stop the trail and make the announcement... OR... is that the day they make the decision and then would need some additional time to prepare the data for an official announcement?

(Trying to nail down a realistic date we should expect to find out the verdict.)

Disclaimer: I am not a professional advisor. Seek professional advice before investing or trading. I take risky positions and do not advise anyone to follow my opinions or actions.